EU Clinical Trial 2018-003471-35

A Multi-Center Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Systemic Lupus Erythematosus  May 29, 2019

Main objective of the trial: To characterize the long-term safety and tolerability of BMS-986165 in subjects with SLE

Parties

Sponsors
Countries
AR AU BR CA DE ES FR HU IL KR MX PL RO RU TW US
Keywords
BMS-986165 Systemic lupus erythematosus synd

JSON preview

Similar records

Title

Source:  EMA Last updated:  Jun 5, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.